Feng Shi

Title: Feng Shi: Innovator in CAR-T Cell Modification

Introduction

Feng Shi is a notable inventor based in Winchester, MA (US), recognized for his contributions to the field of immunotherapy. His innovative work focuses on the modification of CAR-T cells, which are engineered to enhance the immune system's ability to fight cancer.

Latest Patents

Feng Shi holds a patent for the "Modification of CAR-T cells." This patent involves the provision of modified immune cells that express a heterologous polynucleotide. This polynucleotide encodes a function booster, such as an apoptosis inhibitor, which enhances the persistence, proliferation, or cytotoxicity of the modified immune cells. Additionally, the modified T cells may include a chimeric antigen receptor. The patent also covers methods, kits, and components for making and utilizing these modified immune cells.

Career Highlights

Throughout his career, Feng Shi has worked with several prominent organizations, including Dna Twopointo Inc. and The General Hospital Corporation. His experience in these institutions has contributed significantly to his expertise in the field of immunotherapy and cellular modification.

Collaborations

Feng Shi has collaborated with notable colleagues such as Yifang Shui and Jeremy S Minshull. These partnerships have furthered his research and development efforts in the area of CAR-T cell technology.

Conclusion

Feng Shi's innovative work in the modification of CAR-T cells represents a significant advancement in cancer treatment. His contributions to the field are paving the way for more effective immunotherapies.